| Pfizer AG - Clindamycin Pfizer 150 mg, Hartkapseln | | 61556 | | 01 | | Clindamycin Pfizer 150 mg | | Hartkapseln | | J01FF01 | | Clindamycin | | 10.03.2011 | | |
| | Composition | | clindamycinum 150 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 224.13 mg, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Clindamycine | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Clindamycine | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | Lactose Monohydrate | 224.13 mg | | | | | | | | | | | | | | | Propylenglycol | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 16 Gélule(s) | 7.54 | 17.45 | A | LS | Non |
|
|
